Welcome to our dedicated page for Senseonics SEC filings (Ticker: SENS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Senseonics finances next-generation Eversense implants isn’t simple—its 10-K spreads clinical-trial data, FDA milestones, and convertible-note terms across 200+ pages, while each quarterly 10-Q reshapes gross-margin outlooks. Investors asking “What does Senseonics report in their SEC filings?” or searching for “Senseonics insider trading Form 4 transactions” often face dense medical-device language that slows decisive action.
Stock Titan removes that friction. Our AI reviews every Senseonics annual report 10-K simplified, each Senseonics quarterly earnings report 10-Q filing, and all Senseonics 8-K material events explained, then delivers clear, plain-English summaries. Need “Senseonics Form 4 insider transactions real-time”? You’ll get instant alerts the second an executive files. It’s the fastest route for understanding Senseonics SEC documents with AI-driven clarity—no footnote digging required.
We connect filing types to the factors that truly drive this med-tech innovator. Use the 10-K and 10-Q to trace Eversense production costs, partnership revenue with Ascensia, and risk factors tied to long-term sensor accuracy. Dive into the proxy statement executive compensation section to see how milestone-based bonuses align with FDA approvals. Monitor executive stock transactions Form 4 to gauge insider confidence, and compare data across quarters with our “Senseonics earnings report filing analysis” tool. Whether you’re modeling cash burn or evaluating dilution, Stock Titan’s AI-powered summaries, real-time updates, and complete coverage make Senseonics SEC filings explained simply.
Colony Bankcorp, Inc. (CBAN) – Form 4 insider transaction filed 07/02/2025.
CFO Derek Shelnutt reported an “F” transaction code, indicating the surrender of shares to satisfy withholding taxes upon the vesting of restricted stock.
- Shares withheld: 863 common shares at an implied value of $16.53 each (≈ $14.3 thousand).
- Post-transaction holdings: 9,357 shares held directly; 4,786 shares held indirectly through the 401(k) plan, for a total economic interest of 14,143 shares.
No derivative securities were reported, and there were no open-market purchases or sales. The filing is routine, reflecting tax-related share withholding rather than a discretionary sale, and does not materially alter insider ownership or signal a change in strategic outlook.
Colony Bankcorp, Inc. (CBAN) – Form 4 insider transaction filed 07/02/2025.
CFO Derek Shelnutt reported an “F” transaction code, indicating the surrender of shares to satisfy withholding taxes upon the vesting of restricted stock.
- Shares withheld: 863 common shares at an implied value of $16.53 each (≈ $14.3 thousand).
- Post-transaction holdings: 9,357 shares held directly; 4,786 shares held indirectly through the 401(k) plan, for a total economic interest of 14,143 shares.
No derivative securities were reported, and there were no open-market purchases or sales. The filing is routine, reflecting tax-related share withholding rather than a discretionary sale, and does not materially alter insider ownership or signal a change in strategic outlook.
Colony Bankcorp, Inc. (CBAN) – Form 4 insider transaction filed 07/02/2025.
CFO Derek Shelnutt reported an “F” transaction code, indicating the surrender of shares to satisfy withholding taxes upon the vesting of restricted stock.
- Shares withheld: 863 common shares at an implied value of $16.53 each (≈ $14.3 thousand).
- Post-transaction holdings: 9,357 shares held directly; 4,786 shares held indirectly through the 401(k) plan, for a total economic interest of 14,143 shares.
No derivative securities were reported, and there were no open-market purchases or sales. The filing is routine, reflecting tax-related share withholding rather than a discretionary sale, and does not materially alter insider ownership or signal a change in strategic outlook.
Colony Bankcorp, Inc. (CBAN) – Form 4 insider transaction filed 07/02/2025.
CFO Derek Shelnutt reported an “F” transaction code, indicating the surrender of shares to satisfy withholding taxes upon the vesting of restricted stock.
- Shares withheld: 863 common shares at an implied value of $16.53 each (≈ $14.3 thousand).
- Post-transaction holdings: 9,357 shares held directly; 4,786 shares held indirectly through the 401(k) plan, for a total economic interest of 14,143 shares.
No derivative securities were reported, and there were no open-market purchases or sales. The filing is routine, reflecting tax-related share withholding rather than a discretionary sale, and does not materially alter insider ownership or signal a change in strategic outlook.
FAQ
What is the current stock price of Senseonics (SENS)?
What is the market cap of Senseonics (SENS)?
What does Senseonics Holdings Inc specialize in?
How does their technology improve diabetes management?
What are the key components of Senseonics' CGM system?
How does Senseonics differentiate its products from traditional CGM systems?
What markets does Senseonics operate in?
How does Senseonics generate its revenue?
Who stands to benefit from Senseonics' products?
What challenges does Senseonics face in the market?
